A detailed history of Strs Ohio transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Strs Ohio holds 300 shares of FLGT stock, worth $5,193. This represents 0.0% of its overall portfolio holdings.

Number of Shares
300
Previous 7,100 95.77%
Holding current value
$5,193
Previous $139,000 95.68%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$19.6 - $25.06 $133,280 - $170,408
-6,800 Reduced 95.77%
300 $6,000
Q2 2024

Aug 05, 2024

BUY
$19.09 - $22.57 $13,363 - $15,799
700 Added 10.94%
7,100 $139,000
Q1 2024

May 13, 2024

SELL
$21.55 - $29.29 $8,620 - $11,716
-400 Reduced 5.88%
6,400 $138,000
Q4 2023

Jan 30, 2024

SELL
$23.64 - $30.27 $49,644 - $63,567
-2,100 Reduced 23.6%
6,800 $196,000
Q2 2023

Jul 31, 2023

SELL
$28.52 - $40.7 $256,680 - $366,300
-9,000 Reduced 50.28%
8,900 $329,000
Q1 2023

Aug 02, 2023

BUY
$29.39 - $36.27 $264,510 - $326,430
9,000 Added 101.12%
17,900 $558,000
Q3 2022

Oct 27, 2022

BUY
$37.92 - $63.74 $91,008 - $152,976
2,400 Added 15.48%
17,900 $682,000
Q2 2022

Jul 25, 2022

SELL
$47.98 - $62.75 $19,192 - $25,100
-400 Reduced 2.52%
15,500 $845,000
Q1 2022

Apr 21, 2022

BUY
$49.85 - $96.11 $677,960 - $1.31 Million
13,600 Added 591.3%
15,900 $992,000
Q4 2021

Jan 24, 2022

BUY
$77.3 - $105.0 $69,570 - $94,500
900 Added 64.29%
2,300 $231,000
Q3 2021

Oct 22, 2021

BUY
$74.87 - $110.87 $89,844 - $133,044
1,200 Added 600.0%
1,400 $125,000
Q2 2021

Jul 26, 2021

BUY
$66.8 - $100.45 $13,360 - $20,090
200 New
200 $18,000
Q1 2021

Apr 23, 2021

SELL
$59.3 - $183.85 $59,300 - $183,850
-1,000 Closed
0 $0
Q4 2020

Jan 25, 2021

SELL
$31.01 - $52.1 $120,939 - $203,190
-3,900 Reduced 79.59%
1,000 $52,000
Q3 2020

Dec 14, 2020

BUY
$15.89 - $50.51 $66,738 - $212,142
4,200 Added 600.0%
4,900 $196,000
Q2 2020

Jul 23, 2020

BUY
$8.89 - $18.28 $6,223 - $12,796
700 New
700 $11,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $524M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.